HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.1%

Neg 0% Neu 89.1% Pos 0%

HC Wainwright & Co. analyst Brandon Folkes reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Buy and maintains $12 price target.